EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The role of improved molecular genetic testing in the diagnosis of cystic fibrosis – a case series

Nadezhda Yaneva, Mila Baycheva, Dimitrinka Miteva iD, Guergana Petrova iD

Folia Medica · 2025

DOI: 10.3897/folmed.67.e145379 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Folia Medica, 2025. Verfasst von Nadezhda Yaneva und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Maichin Dom, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Genetic Testing. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

 Abstract Cystic fibrosis (CF) is diagnosed through a combination of clinical symptoms, a sweat test, and genetic analysis. Over the last five years, significant advances in cystic fibrosis treatment have been driven by a better understanding of the disease’s genetic basis. This has enabled the development of more sophisticated genetic tests, allowing for more precise treatment for each individual patient. We present a case series of children with clinical presentations suggestive of cystic fibrosis, ambiguous sweat test results, and previous “negative” genetic analysis results. More precise and advanced genetic testing revealed that all three patients carried two CF-causing mutations. In cases where there is high clinical suspicion, despite initial results indicating a negative outcome, we recommend the use of MLPA analysis for the detection of large deletions and insertions that cannot be detected by standard sequencing methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGenetic TestingFemaleHumansMaleMutationChild

Stichwörter der Autor:innen

asthma chromosomal deletion failure to thrive hepatomegaly sweat test

Substanzen

CFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • University Hospital Maichin Dom, Sofia, Bulgaria.
  • Clinic of Pediatric Gastroenterology, Prof. Ivan Mitev University Hospital, Sofia, Bulgaria.
  • Alexandrovska University Hospital, Sofia, Bulgaria.

ORCID-Profile: Dimitrinka Miteva, Guergana Petrova

Zitieren

APA

Yaneva, N., Baycheva, M., Miteva, D., & Petrova, G. (2025). The role of improved molecular genetic testing in the diagnosis of cystic fibrosis – a case series. Folia Medica. https://doi.org/10.3897/folmed.67.e145379

Vancouver

Yaneva N, Baycheva M, Miteva D, Petrova G. The role of improved molecular genetic testing in the diagnosis of cystic fibrosis – a case series. Folia Medica. 2025. doi:10.3897/folmed.67.e145379

BibTeX
@article{Yaneva2025,
  author = {Yaneva, Nadezhda and Baycheva, Mila and Miteva, Dimitrinka and Petrova, Guergana},
  title = {The role of improved molecular genetic testing in the diagnosis of cystic fibrosis – a case series},
  journal = {Folia Medica},
  year = {2025},
  doi = {10.3897/folmed.67.e145379}
}
Kostenlos starten →